The influenza virus has a large impact on global health; however, it is difficult to formulate vaccines and influenza therapies that are effective against influenza. The influenza virus mutates rapidly, has the ability to emerge as novel strains with pandemic potential and can quickly become resistant to any given drug. Therefore, the generation of novel anti-influenza therapeutics that are effective against multiple strains would be highly beneficial. To date, the majority of anti-influenza research has focused on targeting specific components of the virus in order to interfere with its replication. However, it has been proposed that host proteins and signaling pathways may be essential components to viral replication and could also become novel anti-influenza drug targets. Therefore, this study utilized a large proteomic screen to identify host proteins that were up- and down-regulated in response to influenza infection. Collectively, these proteins clustered into five specific cell pathways and processes including interferon signaling, purine metabolism, cell death, ubiquitin-like signaling and mitochondrial oxidoreductases. Overall, this project identified potential novel anti-influenza targets in primary airway epithelial cells. / May 2015

Human epithelium-specific ETS transcription factor-1 (ESE-1), which is also known as E74-like factor-3 (Elf3) in mice, is strongly expressed in lung during fetal development and in certain lung cancers. The primary goal of the work presented in this thesis was to investigate whether ESE-1 is involved in regeneration of the injured lung epithelium by administering naphthalene to both wild-type (Elf3 +/+) and Elf3-deficient (Elf3 -/-) mice. However, optimal conditions for proper utilization of the naphthalene-induced lung injury model must first be established. Therefore, dose-response studies were initially conducted by administering three different doses of naphthalene to both male and female mice, as described in chapter 2. Although it is shown that the extent of naphthalene-induced Clara cell injury is dose-dependent in both male and female mice, female mice are more sensitive to naphthalene-induced injury than male mice independent of the dose. Furthermore, it is also demonstrated that these gender-dependent differences in naphthalene injury can subsequently influence downstream lung repair kinetics. In light of these findings, lung regeneration was examined in both sexes of both Elf3 +/+ and Elf3 -/- mice. As reported in chapter 3, the kinetics of bronchiolar epithelial cell proliferation and differentiation is delayed considerably in Elf3 -/- mice following naphthalene injury. Moreover, expression of transforming growth factor-beta type II receptor, which is a well-known transcriptional target gene of ESE-1 and is involved in the induction of epithelial cell differentiation, is significantly lower in the bronchiolar airway epithelium of Elf3 -/- mice as compared to Elf3 +/+ mice under steady-state conditions and during repair of naphthalene-induced damage. Collectively, these findings occur to a similar extent in both sexes of both Elf3 +/+ and Elf3 -/- mice, and suggest that ESE-1 plays an important role in regulating the kinetics of airway epithelial regeneration after acute lung injury.

Human epithelium-specific ETS transcription factor-1 (ESE-1), which is also known as E74-like factor-3 (Elf3) in mice, is strongly expressed in lung during fetal development and in certain lung cancers. The primary goal of the work presented in this thesis was to investigate whether ESE-1 is involved in regeneration of the injured lung epithelium by administering naphthalene to both wild-type (Elf3 +/+) and Elf3-deficient (Elf3 -/-) mice. However, optimal conditions for proper utilization of the naphthalene-induced lung injury model must first be established. Therefore, dose-response studies were initially conducted by administering three different doses of naphthalene to both male and female mice, as described in chapter 2. Although it is shown that the extent of naphthalene-induced Clara cell injury is dose-dependent in both male and female mice, female mice are more sensitive to naphthalene-induced injury than male mice independent of the dose. Furthermore, it is also demonstrated that these gender-dependent differences in naphthalene injury can subsequently influence downstream lung repair kinetics. In light of these findings, lung regeneration was examined in both sexes of both Elf3 +/+ and Elf3 -/- mice. As reported in chapter 3, the kinetics of bronchiolar epithelial cell proliferation and differentiation is delayed considerably in Elf3 -/- mice following naphthalene injury. Moreover, expression of transforming growth factor-beta type II receptor, which is a well-known transcriptional target gene of ESE-1 and is involved in the induction of epithelial cell differentiation, is significantly lower in the bronchiolar airway epithelium of Elf3 -/- mice as compared to Elf3 +/+ mice under steady-state conditions and during repair of naphthalene-induced damage. Collectively, these findings occur to a similar extent in both sexes of both Elf3 +/+ and Elf3 -/- mice, and suggest that ESE-1 plays an important role in regulating the kinetics of airway epithelial regeneration after acute lung injury.

[Truncated abstract] Atopic asthma pathogenesis is driven by the combined effects of airway inflammation generated during responses to viral infections and aeroallergens, and both of these pathways are regulated by dendritic cells (DC) that differentiate locally from monocytic precursors. These DC normally exhibit a sentinel phenotype characterised by active antigen sampling but attenuated presentation capability, which limits the intensity of local expression of adaptive immunity. How this tight control of airway DC functions is normally maintained and why it breaks down in some atopics leading to immunopathological changes in airway tissues, is unknown. In the airway mucosa, DC are intimately associated with airway epithelial cells (AEC), which are a source of a range of both pro- and anti-inflammatory mediators. A few studies have previously examined the effects of AEC-derived surface-expressed and soluble mediators upon the function of pre-differentiated DC, although there is a dearth of information as to the extent of AEC-conditioning of DC during their generation from incoming monocytic precursors within the airways. Therefore, this study was designed to test the hypothesis that signals from adjacent AEC contribute to regulation of local differentiation of airway mucosal DC, especially in the context of allergic airway disease. A direct co-culture model was developed containing the AEC line 16HBE 14o- as a surrogate for primary AEC, and purified peripheral blood monocytes derived from atopic patients in a GM-CSF/IL-4-enriched cytokine milieu. Cells were cultured for 5 days, at which time the phenotype and functional attributes of the monocyte-derived DC (MDDC) generated in the presence of AEC (AEC-MDDC) were compared to the control MDDC population generated without AEC contact (Ctrl- MDDC). ... In parallel, an attenuation of mRNA boosting for 7 out of 12 selected Th2-asscociated genes as well as IL-13 protein, was observed in AEC-MDDC supplemented cultures compared to ctrl-MDDC supplemented cultures. The data collected in the initial characterisation of the AEC-MDDC in Chapter 3 and further analysis of their gene expression profiles by microarray suggest a number of DC-associated factors could be involved in directing a potential bias against Th2 immunity within the T-cell recall response. These include increased expression of IL- 12 subunit mRNA and the enhanced levels of surface MHC Class II, CD80, ICAM-1 and SLAM. Further to Th1/Th2 modulation, a number of T-regulatory (Treg) genes were differentially expressed in the AEC-MDDC-re-activated CD4+ T-cells, and members of the chemokine and metallothionein families were elevated in the same population. Collectively the results of this study suggest that in the context of the atopic airway microenvironment where there is an abundance of Th2-related mediators, healthy AEC arm locally maturing DC with an arsenal of anti-microbial defences that can be rapidly employed in response to encounter with inhaled pathogens, in particular viruses. In this way, the DC are maintained in an ideal functional phenotype to efficiently mobilise both innate and Th1-polarised adaptive immune defences against infection, whilst achieving tight control of potentially-damaging Th2 immunity to aeroallergens, thus contributing to the maintenance of immunological homeostasis within the respiratory tract.

No description available.

Les cellules souches embryonnaires humaines (CSEh), par leurs caractéristiques de pluripotence et de prolifération illimitée, représentent une alternative à l’utilisation de cellules issues de patients : leur différenciation en cellules épithéliales respiratoires pourrait permettre la production illimitée d’épithélium pour le criblage de molécules thérapeutiques.L’objectif de notre travail a été de mettre au point un protocole simple et financièrement acceptable afin de différencier les CSEh en cellules épithéliales de voies aériennes et de produire un épithélium complet. Pour ce faire, nous avons suivi deux voies potentielles de différenciation des CSEh : une voie passant par la production d’endoderme définitif, feuillet embryonnaire à l’origine de l’épithélium respiratoire, et une voie passant par un progéniteur potentiel commun aux lignages respiratoire et épidermique. Différentes combinaisons de protéines matricielles, d’inducteur de différenciation, de temps d’induction et de milieux de culture ont été testées. Nos résultats montrent que la culture des CSEh sur cellules nourricières STO dans un milieu optimisé pour les cellules bronchiques, le BEGM, en présence de Bone Morphenetic Protein 4 et d’acide rétinoïque pendant 6 jours puis en BEGM seul pendant 30 jours conduit à l’obtention de plus de 76% de progéniteurs épithéliaux respiratoires exprimant des marqueurs spécifiques tels que CK13, P63, CXCR4, FOXA2, SOX17, NKX2.1, SOX2 et SOX9. Le passage par la production de cellules de l’endoderme définitif n’a pas permis d’améliorer l’efficacité de ce protocole. L’isolement de ces progéniteurs et la reconstitution d’un épithélium complet restent à mettre au point. / Human embryonic stem cells (hESCs), for to their characteristics of pluripotency and unlimited proliferation, represent an alternative to the use of primary cells from patients: their commitment and differentiation into airway epithelial cells could help to overcome the lack of patient’s cells and could allow the unlimited production of epithelium for the screening of therapeutic molecules.The objective of our work was to develop a simple and financially acceptable protocol to differentiate hESCs into airway epithelial cells and to produce a complete epithelium. To do this, we followed two potential routes of hESC differentiation: a route through the production of definitive endoderm, the germ layer at the origin of the respiratory epithelium, and a route through a common potential progenitor to the respiratory and epidermal lineages. Various combinations of matrix proteins, differentiation inducers, induction time and culture media were tested.Our results show that hESC culture on STO feeder cells in an optimized medium for human bronchial epithelial cells, the BEGM medium, in the presence of Bone Morphenetic Protein 4 and retinoic acid for 6 days then in BEGM medium alone for 30 supplementary days led to the differentiation of more than 76% of respiratory epithelial progenitors expressing specific markers such as CK13, P63, CXCR4, FOXA2, SOX17, NKX2.1, SOX2 and SOX9. The application of these culture conditions to definitive endoderm cells, previously obtained from hESC, failed to improve the effectiveness of this protocol. The isolation of these progenitors and the reconstruction of a complete airway epithelium remain to be developed.

No description available.

No / Determining bioequivalence for solution pressurized metered dose inhalers (pMDI) is difficult because the critical characteristics of such products are poorly defined. The aim of this study was to elucidate the non-aerodynamic properties of the emitted aerosol particles from two solution pMDI products that determine their biopharmaceutical differences after deposition. Novel particle capture and analysis techniques were employed to characterize the physicochemical and biopharmaceutical properties of two beclomethasone dipropionate (BDP) products: QVAR and Sanasthmax. The BDP particles emitted from the Sanasthmax inhaler were discernibly different those emitted from QVAR in terms of size (50% larger, less porous), solid state (less crystalline) and dissolution (20-fold slower). When deposited onto the surface of respiratory epithelial cell layers, QVAR delivered ∼50% more BDP across the cell layer in 60 min than Sanasthmax. Biopharmaceutical performance was not attributable to individual particle properties as these were manifold with summative and/or competing effects. The cell culture dissolution− absorption model revealed the net effect of the particle formed on drug disposition and was predictive of human systemic absorption of BDP delivered by the test inhalers. This illustrates the potential of the technique to detect the effect of formulation on the performance of aerosolized particles and contribute to assessment of bioequivalence. / This work was in part funded by a grant from the Safety and Environmental Assurance Centre, Unilever Colworth, U.K. Particle sizing was performed by Steve Ingham, Institute of Pharmaceutical Science, King’s College London.

Periciliary liquid (PCL) is a critical component of the respiratory system for maintaining mucus clearance. As PCL homeostasis is affected by evaporation and mechanical forces, which are in turn affected by various breathing conditions, lung morphology and ventilation distribution, the complex process of PCL depth regulation in vivo is not fully understood. We propose an integrative approach to couple a thermo-fluid computational fluid dynamics (CFD) model with an epithelial cell model to study the dynamics of PCL depth using subject-specific human airway models based on multi-detector row computed-tomography (MDCT) volumetric lung images. The thermo-fluid CFD model solves three-dimensional (3D) incompressible Navier-Stokes and transport equations for temperature and water vapor concentration with a realistic energy flux based boundary condition imposed at airway wall. A corresponding one-dimensional (1D) thermo-fluid CFD model is also developed to provide necessary information to the 3D model. Both 1D and 3D models are validated with experimental measurements, and the temperature and humidity distributions in the airways are investigated. Correlations for the dimensionless parameters of Nusselt number and Sherwood number are proposed for characterizing heat and mass transfer in the airways. As one of the key applications of the thermo-fluid CFD model, the water loss rates in the both 1D and 3D airway models are studied. It is found that the secondary flows formed at the bifurcations elevate the regional heat and mass transfer during inspiration and hence the water loss rate, which can only be observed in the 3D models. Among the three human airway models studied in both 1D and 3D, little inter-subject variability is observed for the distributions of temperature and humidity. However, the inter-subject variability could be dramatic for the distribution of water loss rate, as it is greatly affected by airway diameter and regional ventilation. A method is proposed to construct an ion-channel conductance model for both normal and cystic fibrosis (CF) epithelial cells, which couples an existing fluid secretion model with an existing nucleotide and nucleoside metabolism model (collectively named epithelial cell model). The epithelial cell models for both normal and CF are capable of predicting PCL depth based on mechanical stresses and evaporation, and are validated with a wide range of experimental data. With these two models separately validated and tested, the integrated model of the thermo-fluid CFD model and epithelial cell model is applied to MDCT-based human airway models of three CF subjects and three normal subjects to study and compare PCL depth regulation under regular breathing conditions. It is found that evaporative water loss is the dominant factor in PCL homeostasis. Between three types of mechanical forces, cyclic shear stress is the primary factor that triggers ATP release and increases PCL depth. In addition, it is found that that greater diameters of the airways in the 4th-7th generations in CF subjects decrease evaporative water loss, resulting in similar PCL depth as normal subjects. Under regular breathing conditions, the average PCL depths of normal and CF is around 6 to 7 µm, with mechanical forces play a greater role in regulating CF PCL depth. Comparing to 7.68 µm normal base level (considered as optimum PCL depth), this average PCL depth is about 8 to 21% lower. This might suggest that mechanical forces alone cannot entirely balance evaporative water loss, and other mechanisms might be involved.

Para avaliar a capacidade da toxina ExoU de P. aeruginosa de induzir a expressão do fator tissular (FT) por células epiteliais respiratórias da linhagem BEAS-2B, células infectadas pela cepa PA103, produtora da toxina, foram comparadas com outras infectadas por cepa mutante obtida por deleção do gene exoU e com células controles não infectadas quanto a i) expressão do mRNA do FT, por RT-PCR; ii) expressão da proteína FT em lisados celulares, por ensaio imunoenzimático (ELISA), e na superfície celular, por citometria de fluxo; iii) atividade pró-coagulante das células, pela determinação da capacidade de indução de coagulação de plasma humano normal e do lisado celular, através de ensaio colorimétrico; iv) presença de FT solúvel no sobrenadante das culturas, por ELISA; v) liberação de micropartículas expressando FT e fosfatidilserina (FS), por citometria de fluxo. Nossos resultados mostraram que ExoU foi responsável pelo aumento da expressão do mRNA e da concentração da glicoproteína FT tanto nos lisados quanto na superfície celular. Esse aumento foi revertido quando as bactérias foram tratadas com uma droga inibidora de PLA2 (MAFP), comprovando-se a dependência da atividade fosfolipásica A2 de ExoU para a modulação da expressão do FT. Células infectadas pela cepa PA103 induziram uma diminuição no tempo de coagulação do plasma humano normal e o aumento da hidrólise do substrato sintético utilizado no teste colorimétrico em comparação com as células infectadas com a cepa mutante, mostrando que o FT expresso era funcionalmente ativo. Foi também detectado um aumento na concentração de FT solúvel presente nos sobrenadantes de culturas infectadas por PA103 e no número de micropartículas expressando, simultaneamente, FT e FS em relação à cultura infectada pela cepa PA103∆exoU. Os resultados obtidos nos testes in vitro foram validados pela demonstração de que a concentração de FT no parênquima pulmonar de camundongos infectados, por via intratraqueal, com a cepa selvagem foi significativamente superior à detectada nos animais infectados com a cepa mutante. / To evaluate the capacity of the P. aeruginosa toxin ExoU to induce the expression of tissue factor (TF) by epithelial respiratory cells from the BEAS-2B cell line, cells infected with the ExoU-producing PA103 bacterial strain were compared with cells infected with a mutant obtained by deletion of the exoU gene and with control non-infected cells in their i) expression of the TF mRNA, by RT-PCR; ii) expression of the protein TF in cell lisates and surfaces, by enzyme immunoassay (ELISA) and flow cytometry, respectively; iii) procoagulant activity by determining the ability of intact cells to induce the coagulation of normal human plasma and the ability of cell lysates to cleave the synthetic substrate of a chromogenic assay; iv) presence of soluble TF in cell culture supernatants, by ELISA and v) release of microparticles simultaneously expressing TF and phosphatidylserine, by flow cytometry. Cells infected with the wild type bacteria exhibited increased expression of TF mRNA 1 hour after infection and a positive modulation of TF expression in both cell lysates and cell surfaces. The enhancement of TF expression was inhibited when cells were infected with bacteria previously treated with a PLA2 inhibitor (MAFP), confirming that the ability of ExoU to modulate TF expression depended on its phospholipase A2 activity. Newly expressed TF was shown to be functionally active, by both the decrease in the clotting time of human plasma and the enhancement of the hydrolysis of the chromogenic assay substrate. Cells infected with the ExoU-producing bacteria exhibited also higher concentrations of soluble TF and of TF and PS bearing microparticles in the cell culture supernatants. These in vitro results were validated by our finding of increase TF concentrations in the lung parenchyma of mice infected intratracheally with the ExoU producing-bacteria at 24 h post-infection.